SavedAdd your journal

Journals / İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası / 2003 / Cilt: 66 - Sayı: 3

Revision of myxedema coma;A case report

Bir olgu nedeniyle miksödem komasına yeniden bakış

Berrin UMMAN
Doğan ERDOĞAN
Faruk ALAGÖL
Harika BOZTEPE
Hüseyin OFLAZ
Binnur PINARBAŞI
Tolga ÖZYİĞİT
Yılmaz NİŞANCI
Gürsel ACARTÜRK
Orhan KOCAMAN
Pages
178–182
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we report a patient with myxedema coma pre-sented with pericardial effusion and severe electrolyte abnormality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Revision of myxedema coma: A case report.
📊
Key Findings & Data:Even with early detection and appropriate treatment, its mortality is 50 percent on average.
💡
Conclusion & Impact:In this study, we report a patient with myxedema coma pre-sented with pericardial effusion and severe electrolyte abnormality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Revision of myxedema coma: A case report. Myxedema coma is an extreme complication of hypothyroidism in which patients exhibit multiple organ abnormalities and progressive mental deterioration. It occurs when the body's compensatory responses to hypothyroidism are overwhelmed by precipitating factor. While the actual prevalence of myxedema coma is unknown, its fatal nature demands recognition. Even with early detection and appropriate treatment, its mortality is 50 percent on average. In this study, we report a patient with myxedema coma pre-sented with pericardial effusion and severe electrolyte abnormality.

Özet

Miksödem koması, hipotiriodinin çeşitli organ anormallikleri ve ilerleyici mental bozulma ile kendini gösteren nadir, fakat ölümcül bir komplikasyonudur. Vücudun hipotiroidiye kompan-satuar olarak geliştirdiği yanıtı bozan presipitan faktörler, miksödem komasına yol açarlar. Gerçek prevalansı tam olarak bilinmemekle birlikte, hastalığın mortalitesinin çok yüksek olması, erken tanı konulmasını ve tedaviye başlanmasını zorunlu kılmaktadır. Erken tanı ve uygun tedaviye rağmen mortalitesi %50 düzeyindedir. Bu makalede, perikardiyal effüzyon ve ciddi elektrolit bozzuklukları ile prezante olan bir miksödem koması olgusu literatür gözden geçirilerek sunulmuştur.

🔖

Cite This Article

UMMAN, B., ERDOĞAN, D., ALAGÖL, F., BOZTEPE, H., OFLAZ, H., PINARBAŞI, B., ÖZYİĞİT, T., NİŞANCI, Y., ACARTÜRK, G., KOCAMAN, O. (2022). Revision of myxedema coma;A case report. İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası, Cilt: 66 - Sayı: 3, 178–182. https://ajindex.com/articles/553706

References (17)

  1. Aikawa JK: The nature of myxedema: Alterations in the serum electrolyte concentrations and radiosodium space and in the exchangeable sodium and potassium contents. Ann Intern Med 44:30 (1956)
  2. Alagöl F: Tiroid Hastalıkları Endokrinoloji, Metabolizma ve Beslenme Hastalıkları, Editör: Sencer, E.; İ.Ü. İstanbul Tıp Fakültesi Temel ve Klinik Bilimler Ders Kitapları 2001, sayfa 121
  3. Arlot S, Debussche X, Llau JD, Mesmacque A, Tolani M, Quichard J, et al: Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med 17:16 (1991)
  4. Crowley WF, Ridgway EC, Bough EW, et al: Non-invasive evaluation of cardiac function in hypothyroidism. N Engl J Med 296:1 (1977)
  5. Derubertis FR, Michelis MF, Bloom ME, Mintz DH, Field JB, Davis BB: Impaired water excretion in myxedema. Am J Med 51:41 (1971)
  6. Doran GR, Wilkinson JH: The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxedema. Clin Chim Acta 62:203 (1975)
  7. Graettinger JS, Muenster JJ, Checchia CS et al: A corelation of clinical and hemodynamic studies in patients with hypotiroidism. J Clin Invest 37:502 (1957)
  8. Hylander B, Rosengvist U: Treatment of myxedema coma-factors associated with fatal outcome. Acta Endocrinol (Copenh) 108:65 (1985)
  9. Jordan RM: Myxedema coma: Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am 79:185 (1995)
  10. Klein I, Ojamaa K: Thyroid hormone and blood pressure regulation. In: Laragh J, Brenner B, eds. Hypertension, 2nd ed. Newyork. Raven Press 1995, p 2247
  11. Lowe CE, Bird ED, Thomas WC Jr: Hypercalcemia in myxedema. J Clin Endocrinol Metab 22:261 (1962)
  12. Mazonson PD, Williams ML, Cantley LK, Daldorf FG, Utiger RD, Foster JR: Myxedema coma during long term amiodarone theraphy. Am J Med 77:751 (1984)
  13. Ojama K, Balkman C, Klein I: Acute effects of triiodothyronine on arterial smooth muscle cells. Ann Thorac Surg 56:61 (1993)
  14. Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E: Hypothyroidism in elderly. Endocr Rev 8:142 (1987)
  15. Skowsky WR, Kikuchi TA: The role of vasopressin in the impaired water excretion of myxedema. Am J Med 64:613 (1978)
  16. Smalridge RC: Metabolic and anatomic thyroid emergencies: a review. Crit Care Med 20:276 (1992)
  17. Wall CR: Myxedema Coma: Diagnosis and treatment. Am Fam Physician 62:2485 (2000).